Delivery Order SPE2DR25D2104-SPE2DR26F3PUU
- Not listed
- The Defense Logistics Agency awarded a $1,059.48 delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count) on December 11, 2025, with completion scheduled for December 12, 2025. This competitively awarded, firm fixed-price delivery order reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, serving military and veteran healthcare systems. The contract was performed at the company's...
- The Defense Logistics Agency awarded a $3,213.92 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count packages). The order, which carries an ultimate completion date of December 1, 2025, represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively procured with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $1,677.96 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count unit) on November 18, 2025, with completion targeted for November 19, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating open competitive procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order through its Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.30 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xulane 150-35 microgram/day contraceptive patches (3-pack). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Xulane 150-35 microgram/day contraceptive patches (quantity: 3 units). This firm fixed-price delivery order, valued at $10,191.60, represents a non-competitive award under an existing contract vehicle and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. The order falls...
- The Defense Logistics Agency awarded a $35,816.03 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-patch unit). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $11,136.91 for Xulane 150-35 mcg/day contraceptive patches (3-count units) on July 2, 2025, with an ultimate completion date of July 3, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-unit package) with a ceiling value of $1,189.35. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units) valued at $2,602.25. This firm fixed price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 10, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,066.88 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack quantity) on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was awarded without set-aside restrictions through open competition and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transactional purchase under...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PUUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-pack units) valued at $1,714.80. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procurement procedures. The order is set for completion by November 25, 2025, and will be fulfilled from AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's comprehensive federal contract portfolio includes a wide range of pharmaceutical products and medical supplies—from brand-name and generic medications to vaccines and specialized medical devices—distributed across multiple therapeutic domains. This particular delivery order represents one of numerous pharmaceutical supply transactions AmerisourceBergen executes under its prime vendor agreement, demonstrating the company's continued role as a key supplier to the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/23/25 |